Dow Up 0.12% Nasdaq Up 1.35%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
9.46 1.16(13.98%) Oct 20, 4:00PM EDT
Prev Close:8.30
Open:8.49
Bid:5.79 x 300
Ask:10.12 x 1000
1y Target Est:15.27
Beta:2.08
Next Earnings Date:24-Oct-14IMGN Earnings announcement
Day's Range:8.41 - 9.70
52wk Range:7.70 - 18.19
Volume:2,163,388
Avg Vol (3m):976,469
Market Cap:812.68M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMGN

Comparison

Symbol% ChgMkt Cap
IMGNUp 13.98%812.68M
PFE177.10B
RHHBY243.60B
SGEN4.35B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.73
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback